No Data
Merit Medical Systems' (NASDAQ:MMSI) Five-year Earnings Growth Trails the 27% YoY Shareholder Returns
Deals This Week: Smartsheet, AT&T, BP, Cleveland-Cliffs, Vistra and More
Merit Medical Is Maintained at Outperform by Barrington Research
Merit Medical Systems Analyst Ratings
Barrington Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $114
Barrington analyst Michael Petusky maintains $Merit Medical Systems(MMSI.US)$ with a buy rating, and adjusts the target price from $100 to $114.According to TipRanks data, the analyst has a success
Outperform Rating for Merit Medical Systems Bolstered by Positive WAVE Trial Results and Strategic Acquisitions